Xtant Medical Holdings Inc Total Liabilities
Xtant Medical Holdings Inc total liabilities. Based on the latest financial reports, Xtant Medical Holdings Inc (XTNT) has total liabilities worth $43.19 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check XTNT cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Xtant Medical Holdings Inc (2008–2025)
Total liabilities of Xtant Medical Holdings Inc from 2008 to 2025. This chart illustrates how Xtant Medical Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore XTNT strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Xtant Medical Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Xtant Medical Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
FALCON METALS LTD
F:E47
|
Germany | €883.21K |
|
INSUN Environmental New Technology Co. Ltd
KQ:060150
|
Korea | ₩152.93 Billion |
|
Single Well Industrial
TWO:3490
|
Taiwan | NT$788.67 Million |
|
Land Securities Group PLC
LSE:LAND
|
UK | GBX5.00 Billion |
|
KAISER REEF LTD.
F:7YR
|
Germany | €6.14 Million |
|
Uno&Company.Ltd
KQ:114630
|
Korea | ₩12.61 Billion |
|
Turbogen Chp
TA:TURB
|
Israel | ILA30.57 Million |
|
RoyalTek Co Ltd
TWO:3306
|
Taiwan | NT$470.54 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Xtant Medical Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see XTNT asset base.
Liquidity & Leverage Metrics
Xtant Medical Holdings Inc Total Liabilities Ratios Explained
Xtant Medical Holdings Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Xtant Medical Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Xtant Medical Holdings Inc (2008–2025)
The table below shows the annual total liabilities of Xtant Medical Holdings Inc from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $43.19 Million | -15.10% |
| 2024-12-31 | $50.87 Million | +23.29% |
| 2023-12-31 | $41.26 Million | +58.35% |
| 2022-12-31 | $26.06 Million | +9.45% |
| 2021-12-31 | $23.81 Million | -11.66% |
| 2020-12-31 | $26.95 Million | -69.15% |
| 2019-12-31 | $87.36 Million | -3.14% |
| 2018-12-31 | $90.19 Million | -45.14% |
| 2017-12-31 | $164.40 Million | +8.75% |
| 2016-12-31 | $151.17 Million | +12.66% |
| 2015-12-31 | $134.18 Million | +275.59% |
| 2014-12-31 | $35.73 Million | +9.19% |
| 2013-12-31 | $32.72 Million | +8.12% |
| 2012-12-31 | $30.26 Million | +71.28% |
| 2011-12-31 | $17.67 Million | +7.85% |
| 2010-12-31 | $16.38 Million | +182.41% |
| 2009-12-31 | $5.80 Million | +4418.45% |
| 2008-12-31 | $128.38K | -- |
About Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validate… Read more